Abiopharma

Natera - Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress

Organon & Co. - Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada

NIQ and Ogury Collaborate to Enhance Media Planning and Audience Strategy with GeoPurchase Insights

Citi and CREATE-Research Report: Innovation in Asset Management Pivots to ‘Operational Alpha’

Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress

Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA® (ustékinumab), un biosimilaire de référence à STELARA® (ustékinumab) au Canada

Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada

The Confidence Behind VinFasts 10-Year Promise

Alibaba Group Announces Filing of Annual Report on Form 20-F for Fiscal Year 2026

Premier Graphene Inc. (OTC: BIEI) Currently Anticipates Reporting First Profitable Quarter in Company History